A Phase 1, Open-Label, Single-Sequence Study to Examine the Effect of Telaprevir on the Pharmacokinetics of Buprenorphine in Subjects on Stable Buprenorphine/Naloxone Maintenance Therapy.
Phase of Trial: Phase I
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Buprenorphine/naloxone; Telaprevir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
- 07 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2011 New trial record